Search

Your search keyword '"Kerr, Naseem"' showing total 25 results
Start Over Author "Kerr, Naseem"
25 results on '"Kerr, Naseem"'

1. A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma

Author

Qazilbash, Muzaffar H., Saini, Neeraj Y., Cha, Soung-chul, Wang, Zhe, Stadtmauer, Edward A., Baladandayuthapani, Veerabhadran, Lin, Heather, Tross, Beryl, Honhar, Medhavi, Rao, Sheetal S., Kim, Kunhwa, Popescu, Michael, Szymura, Szymon, Zhang, Tiantian, Anderson, Aaron, Bashir, Qaiser, Shpall, Elizabeth J., Orlowski, Robert Z., Levine, Bruce L., Kerr, Naseem, Garfall, Alfred, Cohen, Adam, Vogl, Dan T., Dengel, Karen, June, Carl H., Champlin, Richard, and Kwak, Larry W.

Published
2022
Full Text
View/download PDF

2. Supplementary Table 1 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Author

Rapoport, Aaron P., primary, Aqui, Nicole A., primary, Stadtmauer, Edward A., primary, Vogl, Dan T., primary, Xu, Yin Yan, primary, Kalos, Michael, primary, Cai, Ling, primary, Fang, Hong-Bin, primary, Weiss, Brendan M., primary, Badros, Ashraf, primary, Yanovich, Saul, primary, Akpek, Gorgun, primary, Tsao, Patricia, primary, Cross, Alan, primary, Mann, Dean, primary, Philip, Sunita, primary, Kerr, Naseem, primary, Brennan, Andrea, primary, Zheng, Zhaohui, primary, Ruehle, Kathleen, primary, Milliron, Todd, primary, Strome, Scott E., primary, Salazar, Andres M., primary, Levine, Bruce L., primary, and June, Carl H., primary

Published
2023
Full Text
View/download PDF

3. Supplementary Figure 2 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Author

Rapoport, Aaron P., primary, Aqui, Nicole A., primary, Stadtmauer, Edward A., primary, Vogl, Dan T., primary, Xu, Yin Yan, primary, Kalos, Michael, primary, Cai, Ling, primary, Fang, Hong-Bin, primary, Weiss, Brendan M., primary, Badros, Ashraf, primary, Yanovich, Saul, primary, Akpek, Gorgun, primary, Tsao, Patricia, primary, Cross, Alan, primary, Mann, Dean, primary, Philip, Sunita, primary, Kerr, Naseem, primary, Brennan, Andrea, primary, Zheng, Zhaohui, primary, Ruehle, Kathleen, primary, Milliron, Todd, primary, Strome, Scott E., primary, Salazar, Andres M., primary, Levine, Bruce L., primary, and June, Carl H., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Figure Legends from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Author

Rapoport, Aaron P., primary, Aqui, Nicole A., primary, Stadtmauer, Edward A., primary, Vogl, Dan T., primary, Xu, Yin Yan, primary, Kalos, Michael, primary, Cai, Ling, primary, Fang, Hong-Bin, primary, Weiss, Brendan M., primary, Badros, Ashraf, primary, Yanovich, Saul, primary, Akpek, Gorgun, primary, Tsao, Patricia, primary, Cross, Alan, primary, Mann, Dean, primary, Philip, Sunita, primary, Kerr, Naseem, primary, Brennan, Andrea, primary, Zheng, Zhaohui, primary, Ruehle, Kathleen, primary, Milliron, Todd, primary, Strome, Scott E., primary, Salazar, Andres M., primary, Levine, Bruce L., primary, and June, Carl H., primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figure 3 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Author

Rapoport, Aaron P., primary, Aqui, Nicole A., primary, Stadtmauer, Edward A., primary, Vogl, Dan T., primary, Xu, Yin Yan, primary, Kalos, Michael, primary, Cai, Ling, primary, Fang, Hong-Bin, primary, Weiss, Brendan M., primary, Badros, Ashraf, primary, Yanovich, Saul, primary, Akpek, Gorgun, primary, Tsao, Patricia, primary, Cross, Alan, primary, Mann, Dean, primary, Philip, Sunita, primary, Kerr, Naseem, primary, Brennan, Andrea, primary, Zheng, Zhaohui, primary, Ruehle, Kathleen, primary, Milliron, Todd, primary, Strome, Scott E., primary, Salazar, Andres M., primary, Levine, Bruce L., primary, and June, Carl H., primary

Published
2023
Full Text
View/download PDF

6. Supplementary Figure 1 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Author

Rapoport, Aaron P., primary, Aqui, Nicole A., primary, Stadtmauer, Edward A., primary, Vogl, Dan T., primary, Xu, Yin Yan, primary, Kalos, Michael, primary, Cai, Ling, primary, Fang, Hong-Bin, primary, Weiss, Brendan M., primary, Badros, Ashraf, primary, Yanovich, Saul, primary, Akpek, Gorgun, primary, Tsao, Patricia, primary, Cross, Alan, primary, Mann, Dean, primary, Philip, Sunita, primary, Kerr, Naseem, primary, Brennan, Andrea, primary, Zheng, Zhaohui, primary, Ruehle, Kathleen, primary, Milliron, Todd, primary, Strome, Scott E., primary, Salazar, Andres M., primary, Levine, Bruce L., primary, and June, Carl H., primary

Published
2023
Full Text
View/download PDF

7. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma

Author

Rapoport, Aaron P., Stadtmauer, Edward A., Binder-Scholl, Gwendolyn K., Goloubeva, Olga, Vogl, Dan T., Lacey, Simon F., Badros, Ashraf Z., Garfall, Alfred, Weiss, Brendan, Finklestein, Jeffrey, Kulikovskaya, Irina, Sinha, Sanjoy K., Kronsberg, Shari, Gupta, Minnal, Bond, Sarah, Melchiori, Luca, Brewer, Joanna E., Bennett, Alan D., Gerry, Andrew B., Pumphrey, Nicholas J., Williams, Daniel, Tayton-Martin, Helen K., Ribeiro, Lilliam, Holdich, Tom, Yanovich, Saul, Hardy, Nancy, Yared, Jean, Kerr, Naseem, Philip, Sunita, Westphal, Sandra, Siegel, Don L., Levine, Bruce L., Jakobsen, Bent K., Kalos, Michael, and June, Carl H.

Subjects
Cytokines -- Health aspects, T cells -- Research, Multiple myeloma -- Care and treatment, Biological sciences, Health
Abstract

Despite recent therapeutic advances, multiple myeloma (MM) remains largely incurable. Here we report results of a phase I/II trial to evaluate the safety and activity of autologous T cells engineered to express an affinity-enhanced T cell receptor (TCR) recognizing a naturally processed peptide shared by the cancer-testis antigens NY-ESO-1 and LAGE-1. Twenty patients with antigen-positive MM received an average 2.4 x [10.sup.9] engineered T cells 2 d after autologous stem cell transplant. Infusions were well tolerated without clinically apparent cytokine-release syndrome, despite high IL-6 levels. Engineered T cells expanded, persisted, trafficked to marrow and exhibited a cytotoxic phenotype. Persistence of engineered T cells in blood was inversely associated with NY-ESO-1 levels in the marrow. Disease progression was associated with loss of T cell persistence or antigen escape, in accordance with the expected mechanism of action of the transferred T cells. Encouraging clinical responses were observed in 16 of 20 patients (80%) with advanced disease, with a median progression-free survival of 19.1 months. NY-ESO-1-LAGE-1 TCR-engineered T cells were safe, trafficked to marrow and showed extended persistence that correlated with clinical activity against antigen- positive myeloma., Allogeneic stem cell transplants can eradicate myeloma through the T cell-mediated 'graft-versus-myeloma' (GVM) effect, but their success is limited by morbidity and mortality from infections and organ toxicity. Autologous stem [...]

Published
2015
Full Text
View/download PDF

10. Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

Author

Garfall, Alfred L., primary, Stadtmauer, Edward A., additional, Hwang, Wei-Ting, additional, Lacey, Simon F., additional, Melenhorst, Jan Joseph, additional, Krevvata, Maria, additional, Carroll, Martin P., additional, Matsui, William H., additional, Wang, Qiuju, additional, Dhodapkar, Madhav V., additional, Dhodapkar, Kavita, additional, Das, Rituparna, additional, Vogl, Dan T., additional, Weiss, Brendan M., additional, Cohen, Adam D., additional, Mangan, Patricia A., additional, Ayers, Emily C., additional, Nunez-Cruz, Selene, additional, Kulikovskaya, Irina, additional, Davis, Megan M., additional, Lamontagne, Anne, additional, Dengel, Karen, additional, Kerr, Naseem D.S., additional, Young, Regina M., additional, Siegel, Donald L., additional, Levine, Bruce L., additional, Milone, Michael C., additional, Maus, Marcela V., additional, and June, Carl H., additional

Published
2019
Full Text
View/download PDF

11. Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

Author

Garfall, Alfred L., primary, Stadtmauer, Edward A., additional, Hwang, Wei-Ting, additional, Lacey, Simon F., additional, Melenhorst, Jan Joseph, additional, Krevvata, Maria, additional, Carroll, Martin P., additional, Matsui, William H., additional, Wang, Qiuju, additional, Dhodapkar, Madhav V., additional, Dhodapkar, Kavita, additional, Das, Rituparna, additional, Vogl, Dan T., additional, Weiss, Brendan M., additional, Cohen, Adam D., additional, Mangan, Patricia A., additional, Ayers, Emily C., additional, Nunez-Cruz, Selene, additional, Kulikovskaya, Irina, additional, Davis, Megan M., additional, Lamontagne, Anne, additional, Dengel, Karen, additional, Kerr, Naseem D.S., additional, Young, Regina M., additional, Siegel, Donald L., additional, Levine, Bruce L., additional, Milone, Michael C., additional, Maus, Marcela V., additional, and June, Carl H., additional

Published
2018
Full Text
View/download PDF

12. Pilot Study of Non-Viral, RNA-Redirected Autologous Anti-CD19 Chimeric Antigen Receptor Modified T-Cells in Patients with Refractory/Relapsed Hodgkin Lymphoma (HL)

Author

Svoboda, Jakub, primary, Rheingold, Susan R., additional, Gill, Saar I, additional, Grupp, Stephan A, additional, Lacey, Simon F, additional, Melenhorst, J. Joseph, additional, Kulikovskaya, Irina, additional, Loudon, Brandon, additional, Kerr, Naseem, additional, Marcucci, Katherine T, additional, Shea, Kim-Marie, additional, Schmidt, Aliza, additional, Lledo, Lester, additional, Marshall, Amy, additional, Mato, Anthony R., additional, Dwivedy Nasta, Sunita, additional, Landsburg, Daniel J., additional, Youngman, Matthew R., additional, Levine, Bruce L, additional, Porter, David L, additional, June, Carl H, additional, and Schuster, Stephen J., additional

Published
2017
Full Text
View/download PDF

13. Randomized phase II trial of combination idiotype vaccine and anti-CD3/anti-CD28 costimulated autologous T cells in patients with multiple myeloma post-autotransplantation

Author

Qazilbash, Muzaffar, primary, Stadtmauer, Edward, additional, Baladandayuthapani, Veera, additional, Tross, Beryl, additional, Honhar, Medhavi, additional, Cha, Soungchul, additional, Kim, Kunhwa, additional, Rao, Sheetal, additional, Popescu, Michael, additional, Shah, Nina, additional, Bashir, Qaiser, additional, Patel, Krina, additional, Shpall, Elizabeth, additional, Weber, Donna, additional, Thomas, Sheeba, additional, Shah, Jatin, additional, Orlowski, Robert, additional, Kerr, Naseem, additional, Garfall, Alfred, additional, Cohen, Adam, additional, Dengel, Karen, additional, June, Carl, additional, Champlin, Richard, additional, and Kwak, Larry, additional

Published
2017
Full Text
View/download PDF

14. Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CTL019) in Conjunction with Salvage Autologous Stem Cell Transplantation for Advanced Multiple Myeloma

Author

Garfall, Alfred L., primary, Stadtmauer, Edward A, additional, Maus, Marcela V., additional, Hwang, Wei-Ting, additional, Vogl, Dan T., additional, Cohen, Adam D., additional, Weiss, Brendan M, additional, Porter, David L, additional, Frey, Noelle, additional, Milone, Michael, additional, Mangan, Patricia, additional, Krevvata, Maria, additional, Ayers, Emily, additional, Dengel, Karen, additional, Kerr, Naseem DS, additional, Lacey, Simon F., additional, Melenhorst, Jan Joseph, additional, Ambrose, David E, additional, Chen, Fang, additional, Gonzalez, Vanessa E, additional, Kulikovskaya, Irina, additional, Gupta, Minnal, additional, Finklestein, Jeffrey, additional, Lamontagne, Anne, additional, O'Rourke, Matthew, additional, Suhoski Davis, Megan, additional, Malykhin, Alexander, additional, Levine, Bruce L, additional, and June, Carl H, additional

Published
2016
Full Text
View/download PDF

15. Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation

Author

Qazilbash, Muzaffar H., primary, Stadtmauer, Edward A, additional, Baladandayuthapani, Veera, additional, Lin, Heather, additional, Tross, Beryl M., additional, Honhar, Medhavi, additional, Cha, Soung-Chul, additional, Kim, Kunhwa, additional, Rao, Sheetal S, additional, Popescu, Michael, additional, Shah, Nina, additional, Bashir, Qaiser, additional, Patel, Krina, additional, Shpall, Elizabeth J., additional, Weber, Donna M., additional, Thomas, Sheeba K., additional, Shah, Jatin J., additional, Orlowski, Robert Z., additional, Kerr, Naseem DS, additional, Garfall, Alfred L., additional, Cohen, Adam D., additional, Dengel, Karen, additional, June, Carl H, additional, Champlin, Richard E., additional, and Kwak, Larry, additional

Published
2016
Full Text
View/download PDF

16. Abstract CT105: Safety and feasibility of chimeric antigen receptor modified T cells directed against mesothelin (CART-meso) in patients with mesothelin expressing cancers

Author

Tanyi, Janos L., primary, Haas, Andrew R., additional, Beatty, Gregory L., additional, Morgan, Mark A., additional, Stashwick, Caitlin J., additional, O'Hara, Mark H., additional, Porter, David L., additional, Maus, Marcela V., additional, Levine, Bruce L., additional, Lacey, Simon F., additional, Nelson, Anne Marie, additional, McGarvey, Maureen, additional, Kerr, Naseem DS, additional, Plesa, Gabriela, additional, and June, Carl H., additional

Published
2015
Full Text
View/download PDF

17. Abstract 4701: NY-ESO T cells administered post ASCT for MM exhibit extended functionality without exhaustion in a natural pattern of effector and memory programming

Author

Rapoport, Aaron, primary, Stadtmauer, Edward, additional, Melchiori, Luca, additional, Wong, Ryan, additional, Davila, Eduardo, additional, Binder-Scholl, Gwendolyn, additional, Holdich, Tom, additional, Vogl, Dan, additional, Weiss, Brendan, additional, Finkelstein, Jeffrey, additional, Lacey, Simon, additional, Bond, Sarah, additional, Fortin, Marylene, additional, Peretz, Yoav, additional, Brewer, Joanna, additional, Bennett, Alan, additional, Gerry, Andrew, additional, Pumphrey, Nick, additional, Tayton-Martin, Helen, additional, Ribeiro, Lilliam, additional, Badros, Ashraf, additional, Yanovich, Saul, additional, Hardy, Nancy, additional, Yared, Jean, additional, Kerr, Naseem, additional, Philip, Sunita, additional, Wesphal, Sandra, additional, Levine, Bruce L., additional, June, Carl, additional, Kalos, Michael, additional, and Jakobsen, Bent, additional

Published
2015
Full Text
View/download PDF

18. Safety and efficacy of anti-CD19 chimeric antigen receptor (CAR)-modified autologous T cells (CTL019) in advanced multiple myeloma.

Author

Garfall, Alfred L., primary, Maus, Marcela Valderrama, additional, Lacey, Simon F., additional, Mahnke, Yolanda D., additional, Melenhorst, Jan J., additional, Zheng, Zhaohui, additional, Vogl, Dan T., additional, Cohen, Adam D., additional, Weiss, Brendan M., additional, Dengel, Karen, additional, Kerr, Naseem D.S., additional, Hwang, Wei-Ting, additional, Levine, Bruce, additional, June, Carl H., additional, and Stadtmauer, Edward Allen, additional

Published
2015
Full Text
View/download PDF

19. Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation

Author

Qazilbash, Muzaffar, Stadtmauer, Edward, Baladandayuthapani, Veera, Tross, Beryl, Honhar, Medhavi, Cha, Soung-chul, Kim, Kunhwa, Rao, Sheeta, Popescu, Michael, Shah, Nina, Bashir, Qaiser, Patel, Krina, Shpall, Elizabeth, Weber, Donna, Thomas, Sheeba, Shah, Jatin, Orlowski, Robert, Kerr, Naseem, Garfall, Alfred, Cohen, Adam, Dengel, Karen, June, Carl, Champlin, Richard, and Kwak, Larry

Published
2017
Full Text
View/download PDF

20. Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Author

Rapoport, Aaron P., primary, Aqui, Nicole A., additional, Stadtmauer, Edward A., additional, Vogl, Dan T., additional, Xu, Yin Yan, additional, Kalos, Michael, additional, Cai, Ling, additional, Fang, Hong-Bin, additional, Weiss, Brendan M., additional, Badros, Ashraf, additional, Yanovich, Saul, additional, Akpek, Gorgun, additional, Tsao, Patricia, additional, Cross, Alan, additional, Mann, Dean, additional, Philip, Sunita, additional, Kerr, Naseem, additional, Brennan, Andrea, additional, Zheng, Zhaohui, additional, Ruehle, Kathleen, additional, Milliron, Todd, additional, Strome, Scott E., additional, Salazar, Andres M., additional, Levine, Bruce L., additional, and June, Carl H., additional

Published
2014
Full Text
View/download PDF

21. Engineered T-Cells Expressing An HLA-Restricted Affinity-Enhanced TCR In Advanced Multiple Myeloma Patients Post Auto-SCT Engraft and Are Associated With Encouraging Post Auto-SCT Responses

Author

Rapoport, Aaron P., primary, Stadtmauer, Edward A., additional, Vogl, Dan T., additional, Weiss, Brendan M, additional, Binder-Scholl, Gwendolyn K., additional, Smethurst, Dominic P., additional, Finklestein, Jeffrey, additional, Kulikovskaya, Irina, additional, Gupta, Minnal, additional, Brewer, Joanna E., additional, Bennett, Alan D., additional, Gerry, Andrew B., additional, Pumphrey, Nicholas J., additional, Tayton-Martin, Helen K., additional, Ribeiro, Lilliam C., additional, Badros, Ashraf, additional, Yanovich, Saul, additional, Akpek, Gorgun, additional, Kerr, Naseem, additional, Philip, Sunita, additional, Westphal, Sandra, additional, Levine, Bruce L., additional, Jakobsen, Bent K., additional, Kalos, Michael, additional, and June, Carl H., additional

Published
2013
Full Text
View/download PDF

22. Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT

Author

Rapoport, Aaron P, primary, Stadtmauer, Edward A, additional, Vogl, Dan T, additional, Weiss, Brendan, additional, Binder-Scholl, Gwendolyn K, additional, Smethurst, Dominic P, additional, Finklestein, Jeffrey, additional, Kulikovskaya, Irina, additional, Gupta, Minnal, additional, Brewer, Joanna E, additional, Bennett, Alan D, additional, Gerry, Andrew B, additional, Pumphrey, Nick J, additional, Tayton-Martin, Helen K, additional, Ribeiro, Lilliam, additional, Badros, Ashraf Z, additional, Yanovich, Saul, additional, Akpek, Gorgun, additional, Kerr, Naseem, additional, Philip, Sunita, additional, Westphal, Sandra, additional, Bruce, Levine L, additional, Jakobsen, Bent K, additional, June, Carl H, additional, and Kalos, Michael, additional

Published
2013
Full Text
View/download PDF

23. Abstract 4575: Correlates of clinical response following autologous stem cell transplant and adoptive immunotherapy with engineered T cells expressing an affinity-enhanced T cell receptor in patients with mutliple myeloma.

Author

Rapoport, Aaron P., primary, Stadtmauer, Edward A., additional, Vogl, Dan T., additional, Weiss, Brendan, additional, Binder-Scholl, Gwendolyn K., additional, Smethurst, Dominic P., additional, Finkelstein, Jeffrey, additional, Kulikovskaya, Irina, additional, Gupta, Minnal, additional, Suppa, Erica, additional, Mikheeva, Tatiana, additional, Brewer, Joanna E., additional, Bennett, Alan D., additional, Gerry, Andrew B., additional, Pumphrey, Nick J., additional, Tayton-Martin, Helen K., additional, Ribeiro, Lilliam, additional, Veloso, Elizabeth, additional, Zheng, Zhaohui, additional, Bados, Ashraf Z., additional, Yanovich, Saul, additional, Akpek, Gorgun, additional, Dengel, Karen, additional, Kerr, Naseem, additional, Philip, Sunita, additional, Betts, Kelly-Marie, additional, Westphal, Sandra, additional, Levine, Bruce L., additional, Jakobsen, Bent K., additional, June, Carl H., additional, and Kalos, Michael, additional

Published
2013
Full Text
View/download PDF

24. Adoptive Transfer of Gene-Modified T-Cells Engineered to Express High-Affinity TCRs for Cancer-Testis Antigens (CTAs) NY-ESO-1 or Lage-1, in MM Patients Post Auto-SCT

Author

Rapoport, Aaron P., primary, Stadtmauer, Edward A., additional, Vogl, Dan T., additional, Weiss, Brendan M, additional, Binder-Scholl, Gwendolyn K., additional, Brewer, Joanna E., additional, Bennett, Alan D., additional, Gerry, Andrew B., additional, Pumphrey, Nick J., additional, Smethurst, Dominic P., additional, Tayton-Martin, Helen K., additional, Lilliam, Ribeiro C., additional, Veloso, Elizabeth, additional, Zheng, Zhaohui, additional, Badros, Ashraf Z., additional, Yanovich, Saul, additional, Akpek, Gorgun, additional, McConville, Holly, additional, Kerr, Naseem, additional, Philip, Sunita, additional, Betts, Kelly-Marie, additional, Westphal, Sandra, additional, Kalos, Michael, additional, Levine, Bruce L., additional, Jakobsen, Bent K., additional, and June, Carl H., additional

Published
2012
Full Text
View/download PDF

25. Randomized Phase II Trial of Combination Idiotype Vaccine and Adoptive Cell Transfer of Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation

Author

Qazilbash, Muzaffar H., Stadtmauer, Edward A, Baladandayuthapani, Veera, Lin, Heather, Tross, Beryl, Honhar, Medhavi, Cha, Soung-chul, Kim, Kunhwa, Popescu, Michael, Shah, Nina, Bashir, Qaiser, Patel, Krina K., Lee, Vincent Young, Shpall, Elizabeth J, Weber, Donna M., Thomas, Sheeba K., Orlowski, Robert Z., Kerr, Naseem, Garfall, Alfred L., Cohen, Adam D., Vogl, Dan T., Dengel, Karen, June, Carl H, Champlin, Richard E, and Kwak, Larry W

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results